IGF-1 LR3 For Sale — Research Grade
PX1 Research supplies high-purity, synthetic Long Arg3 Insulin-like Growth Factor-1 (IGF-1 LR3) engineered specifically for in vitro and preclinical research applications. Every batch undergoes rigorous HPLC and Mass Spectrometry validation to ensure precise chemical identity, strict endotoxin compliance, and lot-to-lot consistency. Explore our USA-synthesized reagents with immediate order processing and same-day dispatch from our California and Arizona logistics hubs.
Quick answer
PX1 Research supplies high-purity, synthetic Long Arg3 Insulin-like Growth Factor-1 (IGF-1 LR3) engineered specifically for in vitro and preclinical research applications. Every batch undergoes rigorous HPLC and Mass Spectrometry validation to ensure precise chemical identity, strict endotoxin compliance, and lot-to-lot consistency. Explore our USA-synthesized reagents with immediate order processing and same-day dispatch from our California and Arizona logistics hubs.
Key takeaways
- Insulin-like Growth Factor-1 Long Arg3 ([IGF-1 LR3](/research-peptides/igf-1-lr3)) is a synthetic recombinant analogue of human IGF-1 designed to overcome the analytical limitations of wild-type growth factors in cell culture and tissue model studies.
- The molecular architecture of [IGF-1 LR3](/research-peptides/igf-1-lr3) includes two distinct modifications relative to the 70-amino acid sequence of endogenous IGF-1.
- When evaluating options to [buy IGF-1 LR3 for laboratory use](/product/igf-1-lr3), analytical rigor is paramount.
- Reliable baseline data depend upon supplier consistency and material traceability.
Overview of IGF-1 LR3 in Preclinical Laboratory Research
Insulin-like Growth Factor-1 Long Arg3 (IGF-1 LR3) is a synthetic recombinant analogue of human IGF-1 designed to overcome the analytical limitations of wild-type growth factors in cell culture and tissue model studies. In standard in vitro assays, native IGF-1 binds rapidly to endogenous IGF-binding proteins (IGFBPs), which neutralize or obscure its biological activity and complicate signaling measurements. IGF-1 LR3 addresses this obstacle through structural modifications that drastically reduce affinity for IGFBPs while maintaining full target receptor binding capabilities.
Investigators who search for high-purity IGF-1 LR3 research peptide reagents often require standardized, high-potency growth factors capable of operating predictably in culture media. Because native IGF-1 exhibits a biological half-life measured in minutes within aqueous or serum-containing assays, the structural integrity of IGF-1 LR3 makes it a vital tool for studying prolonged downstream signal transduction, mitogenesis, and cellular differentiation without frequent media replenishment or protein turnover complications.
Structural Biochemistry and Receptor Affinity Dynamics
The molecular architecture of IGF-1 LR3 includes two distinct modifications relative to the 70-amino acid sequence of endogenous IGF-1. First, an additional 13-amino acid N-terminal extension peptide is attached. Second, a glutamic acid (Glu) residue at position 3 is substituted with an arginine (Arg) residue. Together, these modifications yield an 83-amino acid polypeptide with a molecular weight of approximately 9.1 kDa.
Preclinical studies suggest that the substitution at position 3, combined with the N-terminal extension, alters the steric configuration of the peptide in a way that minimizes electrostatic interactions with IGFBPs. In vitro competitive binding assays demonstrate that IGF-1 LR3 exhibits an affinity for IGFBPs that is less than 1% of native IGF-1. Crucially, the domain responsible for binding to the Type 1 IGF Receptor (IGF-1R) remains fully functional. Consequently, the concentration of free, active ligand in cell culture systems remains significantly elevated over extended incubation periods, facilitating clear visualization of transmembrane signaling cascade events.
Evaluating Sourcing Standards: Purity, Identity, and Endotoxin Control
When evaluating options to buy IGF-1 LR3 for laboratory use, analytical rigor is paramount. Recombinant peptides synthesized for cellular bioassays must meet strict quantitative purity thresholds to prevent false experimental outcomes, cytotoxicity, or receptor desensitization driven by truncated peptide fragments or bacterial contaminants.
At PX1 Research, every batch of IGF-1 LR3 is processed in state-of-the-art facilities and subjected to independent validation by an ISO 17025 accredited laboratory. Our purity verification protocols mandate a minimum purity threshold of 98% as measured by High-Performance Liquid Chromatography (HPLC). Mass Spectrometry (MS) analysis is performed simultaneously to confirm exact molecular mass and primary sequence fidelity. Furthermore, because recombinant growth factors are synthesized using expression systems that can introduce lipopolysaccharides, all lots undergo chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below regulatory thresholds (<0.1 EU/mg).
Why Laboratory Investigators Partner with PX1 Research
Reliable baseline data depend upon supplier consistency and material traceability. PX1 Research serves as a direct domestic resource for academic, biotechnology, and institutional research teams requiring premium research peptides synthesized under strict quality controls.
All PX1 products are domestic in origin and managed within cGMP-compliant manufacturing environments. Orders placed before 1:00 PM PST ship the same business day from our secure distribution facilities located in California and Arizona. This dual-hub infrastructure minimizes transit times and thermal exposure during transit. Every shipment includes a lot-specific, publicly accessible Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectra, and endotoxin assay results, ensuring total transparency for peer-reviewed research documentation.
Preclinical Applications: Cell Proliferation, Differentiation, and Hyperplasia
In vitro data indicate that IGF-1 LR3 plays a central role in modulating cellular growth, protein synthesis, and proliferation across multiple cell lines. The primary downstream effector of IGF-1 LR3 activation is the Phosphoinositide 3-kinase (PI3K) / Akt signal transduction cascade, alongside the Mitogen-Activated Protein Kinase (MAPK/ERK) pathway. When IGF-1 LR3 binds to IGF-1R, receptor autophosphorylation triggers phosphorylation of Insulin Receptor Substrate (IRS) proteins, initiating downstream signaling.
In cell culture models of skeletal muscle (such as C2C12 myoblasts), preclinical studies suggest that exposure to IGF-1 LR3 accelerates myoblast proliferation and promotes fusion into multinucleated myotubes. Furthermore, research models examining satellite cell activation show marked upregulation of myogenic regulatory factors including MyoD and myogenin. Because the compound remains active without rapid binding-protein sequestration, researchers utilize IGF-1 LR3 to analyze long-term metabolic processes, amino acid uptake rates, and cellular hyperplastic signaling in tissue engineering assays.
Comparative Analysis: IGF-1 LR3 vs. Other Somatotropic and Myogenic Analogues
Understanding how IGF-1 LR3 compares to related peptides within the somatotropic and myogenic growth factor axes is essential for designing appropriate target experiments. While IGF-1 LR3 provides extended receptor activation in vitro due to suppressed IGFBP binding, alternative sequence modifications yield distinct kinetic profiles suited for localized or transient assays.
For instance, IGF-1 DES is a truncated 67-amino acid variant lacking the N-terminal tripeptide (Gly-Pro-Glu). This modification also impairs IGFBP binding but results in a dramatically shorter systemic half-life and elevated local potency, making it popular for pulse-stimulation cellular studies. Conversely, Pegylated MGF (Mechano Growth Factor) is a splice variant of IGF-1 conjugated to a polyethylene glycol chain, optimized specifically for investigating mechanical overload signaling and tissue repair mechanisms. For research focusing on endogenous growth hormone secretion rather than direct growth factor receptor stimulation, secretagogues such as CJC-1295 DAC act on the pituitary GHRH receptor rather than directly binding IGF-1R. Choosing the correct analogue depends on whether the protocol requires direct extracellular ligand-receptor interaction or upstream endocrine axis manipulation.
Laboratory Handling, Reconstitution, and Storage Protocols
To maintain structural stability and prevent peptide degradation, proper laboratory handling protocols must be observed upon receipt of lyophilized IGF-1 LR3. Lyophilized peptides should be stored in a freezer at -20°C or -80°C away from light until reconstitution. Under these conditions, the unconstitution reagent maintains chemical integrity for extended periods.
Reconstitution should be performed using sterile laboratory reagents, such as 0.1M acetic acid or sterile 0.9% sodium chloride, depending on the specific requirements of the downstream cell culture media or assay buffer. To prevent aggregation, avoid high-shear vortexing; gently swirl or invert the vial until the cake is fully dissolved. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles and stored at -20°C or kept refrigerated at 2°C to 8°C for immediate short-term experimental workflows. Detailed handling protocols can be referenced in the PX1 research library.
Understanding HPLC and MS Certification in Reagent Selection
A critical step when selecting a vendor for IGF-1 LR3 research peptide reagents is verifying analytical documentation. High-Performance Liquid Chromatography (HPLC) separates chemical components in a column matrix to quantify overall purity, yielding a chromatogram where the primary peak represents target sequence concentration. A purity value exceeding 98% ensures that secondary peaks (representing synthesis artifacts or truncated sequences) are minimized to non-interfering levels.
Mass Spectrometry (MS) complements HPLC by verifying molecular mass. The resulting mass spectrum reveals the exact charge-to-mass ratio ($m/z$), confirming that the observed peak on the HPLC chromatogram corresponds precisely to the 83-amino acid structure of IGF-1 LR3 (molecular weight ~9,111 Da). Every order fulfilled by PX1 Research includes batch-specific analytical reports accessible directly on our platform, setting the standard for verifiable quality in peptide procurement.
Institutional Procurement and Wholesale Research Accounts
PX1 Research works directly with academic institutions, contract research organizations (CROs), and private biotechnology facilities requiring consistent, large-scale peptide supply. We offer flexible procurement pipelines tailored to institutional purchasing guidelines, including net terms, dedicated account management, and bulk unit pricing.
Principal investigators and laboratory managers seeking recurring supply schedules or custom bulk quantities can submit inquiries through our wholesale procurement accounts portal. Institutional orders undergo the same rigorous batch-level HPLC/MS quality verification and domestic same-day dispatch standards, ensuring seamless integration into ongoing research timelines.
Regulatory Statement and Intended Laboratory Scope
All products distributed by PX1 Research, including IGF-1 LR3, are strictly synthesized and sold for in vitro, laboratory, and preclinical research applications only. They are not intended for human or animal consumption, diagnostic procedures, therapeutic treatments, or clinical administration.
Purchasing entities are responsible for adhering to local, state, and federal regulations regarding the acquisition, handling, and disposal of synthetic research peptides.PX1 Research enforces strict verification safeguards to ensure that all compounds are delivered exclusively to qualified research facilities and professional investigators.
Frequently Asked Questions
What is the primary difference between native IGF-1 and IGF-1 LR3 in research?
IGF-1 LR3 contains an N-terminal 13-amino acid extension and a Glu3Arg substitution. This modification significantly reduces its affinity for IGF-binding proteins (IGFBPs) by over 99%, leading to a much longer effective half-life and greater bioactivity in cell culture assays compared to native IGF-1.
How does PX1 Research verify the purity of its IGF-1 LR3?
Every batch of IGF-1 LR3 undergoes High-Performance Liquid Chromatography (HPLC) to confirm a purity level of 98% or higher, Mass Spectrometry (MS) to verify exact molecular weight, and LAL testing to ensure endotoxin levels are below 0.1 EU/mg. Validation is conducted by independent ISO 17025 accredited testing facilities.
What solvent is recommended for reconstituting lyophilized IGF-1 LR3?
For stable long-term stock solutions, IGF-1 LR3 is commonly reconstituted in sterile 0.1M acetic acid or dilute hydrochloric acid (pH 2-3) before diluting into culture media. Reconstitution guidelines depend on specific assay protocols. Avoid vigorous vortexing during solubilization.
How should IGF-1 LR3 be stored upon arrival at the laboratory?
Lyophilized IGF-1 LR3 should be stored at -20°C or -80°C upon receipt to maintain long-term stability. Once reconstituted in an appropriate buffer, stock aliquots should be frozen at -20°C or kept short-term at 2°C to 8°C. Avoid repeated freeze-thaw cycles.
What are the shipping timelines for IGF-1 LR3 orders from PX1 Research?
Orders placed before 1:00 PM PST Monday through Friday ship same-day from our CA or AZ distribution centers. Peptides are packaged securely to protect structural integrity during domestic transit.
Is IGF-1 LR3 suitable for clinical or veterinary administration?
No. IGF-1 LR3 supplied by PX1 Research is strictly designated for in vitro, laboratory, and preclinical research purposes only. It is explicitly not for human or animal therapeutic, diagnostic, or clinical use.
What is the endotoxin limit for PX1 Research IGF-1 LR3 lots?
PX1 Research enforces a strict endotoxin limit of less than 0.1 EU/mg for recombinant peptides, verified via chromogenic LAL assays to prevent endotoxin-induced interference in cell culture experiments.
Can institutions set up wholesale accounts for bulk peptide purchasing?
Yes. Academic laboratories, CROs, and industrial research facilities can apply for institutional pricing and bulk ordering through the PX1 Research wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.